sunitinib g.l. pharma 12,5 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib g.l. pharma 25 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 25 mg
sunitinib g.l. pharma 50 mg cietās kapsulas
g.l. pharma gmbh, austria - sunitinibs - kapsula, cietā - 50 mg
sunitinib zentiva 12,5 mg cietās kapsulas
zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib zentiva 50 mg cietās kapsulas
zentiva, k.s., czech republic - sunitinibs - kapsula, cietā - 50 mg
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiski līdzekļi - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
sunitinib krka 25 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 25 mg
sunitinib krka 50 mg cietās kapsulas
krka, d.d., novo mesto, slovenia - sunitinibs - kapsula, cietā - 50 mg
sunitinib norameda 12,5 mg cietās kapsulas
norameda uab, lithuania - sunitinibs - kapsula, cietā - 12,5 mg
sunitinib norameda 50 mg cietās kapsulas
norameda uab, lithuania - sunitinibs - kapsula, cietā - 50 mg